Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Oliver & Co who wrote (5309)	9/15/1998 6:14:00 PM
From: Steve Fancy	Read Replies (1) \| Respond to of 6136

Oliver, could be, but just doesn't seem that news on AG3340 phase II trials would be responsible for the huge gains of the last week or so. I suspect something else is/was driving the stock, and as it appeared to falter for the first time in days above the 30 level yesterday, then again today at the 28 level that we saw some profit taking set in from the folks who bought at the low 20's. 28 is really the first barrier...I had hoped we had taken it out. I'd like to hear some solid news on Reumune. Wondering if we're still on track to submit for FDA approval next spring. I'm not understanding the lack of enthusiasm. sf